Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
98076663	9807666	3	F	20110428	20160706	20140110	20160815	EXP		US-ROCHE-782749	ROCHE		60.00	YR		F	Y	39.10000	KG	20160815		MD	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FREQ
98076663	9807666	1	PS	Vismodegib	VISMODEGIB	1	Oral	21 DAY CYCLE (150 X 21= 3150 MG PER CYCLE)?DATE OF MOST RECENT DOSE PRIOR TO SAES WAS ON 27 APR 2011	U	203388	150	MG	QD
98076663	9807666	2	SS	CISPLATIN.	CISPLATIN	1	Intravenous (not otherwise specified)	CYCLE = 21 DAYS?DATE OF MOST RECENT DOSE PRIOR TO SAES WAS ON 27 APR 2011 AT 100 MG	U	0	75	MG/M**2
98076663	9807666	3	SS	ETOPOSIDE.	ETOPOSIDE	1	Intravenous (not otherwise specified)	CYCLE = 21 DAYS?DATE OF MOST RECENT DOSE PRIOR TO SAES WAS ON 27 APR 2011 AT 133 MG	U	0	100	MG/M**2

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
98076663	9807666	1	Small cell lung cancer
98076663	9807666	2	Small cell lung cancer
98076663	9807666	3	Small cell lung cancer

Outcome of event

Event ID	CASEID	OUTC COD
98076663	9807666	HO

Reactions reported

Event ID	CASEID	PT
98076663	9807666	Decreased appetite
98076663	9807666	Dehydration
98076663	9807666	Hip fracture
98076663	9807666	Lung infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
98076663	9807666	1	20110330	20110427
98076663	9807666	2	20110330	20110427
98076663	9807666	3	20110330	20110427